Our mission is to revolutionize healthcare by developing innovative precision medicine technologies for every patient.
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called...Read more
Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have...Read more
A Multidisciplinary Approach
Englander Institute for Precision Medicine
Belfer Research Building
New York, NY 10021